Прогностическая роль изменений молекулярного полиморфизма пролактина во время беременности
Диссертация
Разнородность этиологии феномена макропролактинемии способствует формированию различных молекулярных форм пролактина при беременности (Булатов А., 1997, Найоп N. е1 а1, 2008). В большинстве исследований учитывается именно процентное содержание макропролактина, а не абсолютные значения пролактина и его фракций. Попытки выявить зависимость между общей концентрацией гормона, уровнем макропролактина… Читать ещё >
Список литературы
- Балаболкин М.И., Герасимов Г. А. Пролактин: клинические аспекты. // М. ВНИИМИ.-1988.- С. 62.
- Берштейн Л.М., Зимарина Т. С., Цырлина Е. В. Генетический полиморфизм ферментов стероидогенеза и содержание рецепторов в опухолях репродуктивной системы. // Вопросы онкологии,-2004.- Т.-50(2).- С. 169 172.
- Булатов A.A. Молекулярный полиморфизм гормона роста и пролактина и его клиническое значение// Пробл. Эндокринол. -1990.№ 2.- С. 30−35.
- Булатов A.A. Феномен макропролактинемии, его происхождение и клинико-диагностическое значение. // Пробл. эндокринол. — 1997. — Т. 43,—№ 3. —С. 50−55.
- Булатов A.A., Макаровская Е. Е., Макарова Е. И. Связывание пролактина в сыворотке крови при различных формах гиперпролактинемии. // Пробл. эндокринол. 1998. — т. 44, № 2. — С. 32−35.
- Булатов A.A., Мартынов A.B., Смирнова Н. Б. Биохимическая природа высокомолекулярного пролактина сыворотки крови человека: идентификация пролактинсвязывающего белка. // Биохимия 1997- С. 1212−1220.
- Вакс В.В. Гиперпролактинемия: причины, клиника, диагностика и лечение. // Consilium-Medicum. 2001 — Т. 3. № 11 — стр. 516−524.
- Вихляева Е.М. Руководство по гинекологической эндокринологии. М.: Мед информ. агентство, 2002. — С. 206, 363
- Ю.Горгошидзе Б. В. Особенности секреции иммунореактивного инсулина, гормона роста и кортизола у больных с синдромом гиперпролактинемии: Автореф. дис. канд. мед. наук, М., 1984. -С. 18.
- Дедов И.И., Мельниченко Г. А., Романцова Т. И., и др. Гиперпролактинемия. Современные подходы и старые проблемы.// Вестник репродуктивного здоровья. 2009. № 2. С. 2−8.
- Демидов В.Н., Розенфельд Б. Е., Воеводин С. М., Логвиненко A.B. Ультразвуковая биометрия плода при физиологически развивающейся беременности (нормативы и сравнительная точность). // SonoAce-Ultrasound 2001. № 8 С. 31−39
- Дзеранова Л.К., Табеева К. И. Гончаров Н.П., Колесникова Г. С., Добрачева А. Д. Макропролактинемия //Проблемы репродукции 2005. № 2. С. 46−53.
- Игонина H.A., Кондрашева Е. А., Макарова Т. А., Чащихина Е. В. Скрининг на макропролактин пациентов с гиперпролактинемией: опыт применения в рутинной лабораторной практике // Клиническая и лабораторная диагностика 2007- 5: 35−6.
- Иловайская И. А., «Нетипичные» формы синдрома гиперпролактинемии: клинические варианты, особенности диагностики и лечения: Дис. канд. мед. наук.-М., 1994.
- Иловайская И. А., Крюкова И. В., Кеда М. Ю. и соавт. Роль антигипофизарных антител в патогенезе гиперпролактинемии // Проблемы эндокринологии. 2002 — Т. 48.№ 3 — стр. 6−9.
- Иловайская И.А., Марова Е. И. Биология пролактина. Молекулярные формулы пролактина // Акушерство и гинекология, — 2000.- N6.- С.3−6.
- Камилова Д.П., Сперанская Н. В., Шипов М. Н. Диагностика нарушений репродуктивной функции и пациенток с нормопролактинемической галактореей // Акушерство и гинекология. 1997(3).- С. 22−25.
- Кветной И.М., Айламазян Э. К., Лапина Е. А., Колобов A.B. Сигнальные молекулы-маркеры зрелости плаценты // М.:МЕДпресс-информ-2005.
- Макаровская Е.Е., Иловайская И. А., Мартынов A.B. Клинико-биохимические корреляции у пациентов с преобладанием высокомолекулярного пролактина в сыворотке крови.// Пробл. эндокринол. 1995.-т. 41, № 1,-С. 17−19.
- И.Марова Е. И., Вакс В. В., Дзеранова Л. К. Гиперпролактинемия у женщин и мужчин. // М.: Pharmacia and Upjohn 2000. — С. 43.
- Мельниченко Г. А, Гончаров Н. П., Дзеранова Л. К, Бармина И. И. Клинические и лабораторные аспекты феномена макропролактинемии // Вестник РАМН. 2007. № 3. С. 52−54.
- Побединский Н.М., Болтуцкая О. И., Омельяненко А. И. Стероидные рецепторы нормального эндометрия.// Акуш. и гин. 2000 — № 3 — С.-5.
- Прилепская В.Н. Особенности течения беременности у женщин с гиперпролактинемией различного генеза. // Материалы научной конференции «Экстрагенитальная патология и беременность». М., 1986 г. -с. 135−139.
- Семенова Н.В. Течение беременности и родов у больных с гиперпролактинемией различного генеза после лечения парлоделом: Дис. канд. мед. наук.-М.-1989.
- Серебрянский О.Ю., Романцова Т. И., Мельниченко Г. А. Естественное течение нелеченной гиперпролактинемии.// Терапевтичический архив. 2001. Т. 73. № 12. С. 101−105.
- Сметник В.П. Типы заместительной гормонотерапии. // Гинекология-2000.Т. 2(5).-С.-133−136.
- Сидельникова В.М. Эндокринология беременности в норме и при патологии. Москва. МЕДпресс-информ. 2007 г., 351 с
- Соснова Е.А. Особенности состояния репродуктивной системы у пациенток с гиперпролактинемическим синдромом: Автореф. дис. канд. мед. наук, М, 2006, — С.-32.
- Спарк Р. Нарушение секреции пролактина. Пер. с англ. // Эндокринология под ред. Н. Левина. М.: Практика, 1999.- С.-160−172.
- Ahlquist J., Dearman G, Fahie-Wilson M.N. Differential effects of pregnancy on different high molecular mass forms of serum prolactin// British Endocrine Societies Joint Meeting, 2005.
- Amadori P., Dilberis C., Marcolla A. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.// Eur J Endocrinol. 2004.- Vol. 150(1), P.- 93−96.
- Andersen J.R. Decidual prolactin. Studies of decidual and amniotic prolactin in normal and pathological pregnancy // Dan Med Bull 1990- 37: 154−65.
- Arias M., Pereiro I., Requena I. et al. Malignant prolactinoma with intra- and extracranial metastasis: clinico-radiological study// J.Phys. Med. Rehabil.-2000.-V.79.-№ 4.-P.-343−348.
- Atkins D., Best D., Briss P.A., et al. Grading quality of evidence and strength of recommendations.// BMJ. 2004. Vol. 328, .№ 7454. P. 1490.
- Bachelot A. Binart N. Reproductive role of prolactin // Repoduction. 2007. -Vol. 133.-pp.'361−369.
- Barberia J.M., Abu-Fadil S., Kletzky O.A. Serum prolactin patterns in early human gestation. // Obstet. Gynecol.-1975.-Vol. 121(8), P.-1107−1110.
- Belaisch-Allart J., Mouzon J. de, Lapousterle C. The effect of HCG supplementation after combined GnRH agonist / HMG treatment in an IVF programme. Hum. Reprod., — 1990., — vol. 5., -№ 5., — pp.163−166.
- Ben Nun I., Jaffe R., Fejgin MD et al. Therapeutic maturation of endometrium in vitro fertilisation and embrio transfer. Fertil. Steril 1992- 57: 953−62.
- Bigazzi M., Nardi E. Prolactin and relaxin: antagonism on the spontaneous motility of the uterus. // J. Clin. Endocrinol. Metab. 1981.-Vol. — 53(3), P. 665−667.
- Bjoro T. Morkrid L., Frequen J. Frequency of hyperprolactinemia due to large molecular weight prolactin // Scand J Clin Lab Invest. 1995. — Vol. 55. — pp. 139−147.
- Bolanowski M. Challenges in the management of hyperprolactinemia // ENEA abstract book. 2010. MTP 1. P. 21
- Bonhoff A Vuille JC, Gomez F, Gellersen B. Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex. // Exp Clin Endocrinol Diabetes. 1995. — Vol. 103. — pp. 252−255.
- Brue T., Caruso E., Morange I. et al. Immunoradiometric analysis of circulating human glycosylated and nonglycosylated prolactin forms: spontaneous and stimulated secretions. //J Clin. Endocrinol. Metab. 1992. Vol.-75(5).-P. 133 844.
- Casanueva F.F., Molitch M.E., Schlechte J.A. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.// Clin. Endocrinol. (Oxf.). 2006. Vol. 65. № 2. P. 265−273.
- Carlson H.E., Markoff E., Lee D.W. On the nature of serum prolactin in two patients with macroprolactinemia. // Fertil Steril. 1992. — 1: Vol. 58. — pp. 7887.
- Cavaco B., Leite V., Santos M.A. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma. // J. Endocrin. Invest.-1995.-Vol.80 (8).-P.-2342−6.
- Chen BL Zhang ZH, Liu NB, Huang KS. Prolactin in normal pregnancy and severe pregnancy-induced hypertension. // Hunan Yi Ke Da Xue Xue Bao. -2001 Vol 26. — pp. 67−69.
- Chitlange S.M., Hazari K.T., Joshi J.V. et al. Ultrasonographically observed preterm grade III placenta and perinatal outcome// J. of Gynecology and Obstetrics 1990, — Vol.3l, No.4.- P.325−328.
- Choi B.C., Polgar K., Xiao L. et al. Progesterone inhibits in-vitro embryotoxic Thl cytokine production to trophoblast in women with recurrent pregnancy loss. // Hum. Reprod-2000. Vol.15.- P.46−59.
- Clapp C., Lopez-Gomez FJ, Nava G. et al. Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects. // J Endocrinol. 1998. — 1: Vol. 158. — pp. 137−144.
- Clevenger C.V., Plank T.L. Prolactin as an autocrine/paracrine factor in breast tissue//J. Gland. Biol.neoplasia.-1997.-V.2(l).P.-59−68
- Cooke N.E., Coit D., Shine J. et al. Human prolactin: cDNA structural analysis and volutionary comparisons. // J.Biol.Chem. 1981 .- Vol.256,No.8.- P.4007−4016.
- Corbacho AM Macotela Y, Nava G. et al. Human umbilical vein endothelial cells express multiple prolactin isoforms. // J. Endocrinol.. 2000. — 1: Vol. 166.-PP- 53−62.
- Dalkin A.C., Marshall J.C. Medical therapy of hyperprolactinemia. //Endocrin. Metabol. Clin. North Am. 1989.-Vol. -13, P.-253−276.
- Donadio F., Barbieri A., Angioni R et al. Patients with macropralactinaemia: clinical and radiological features.// Eur. J. Clin. Invest. 2007. Vol. 37. № 7. P. 552−557.
- E1US AR, Fahie-Wilson MN, Axcell M, Sands K, Hill RP. Macroprolactin (s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum. Ann Clin Biochem 2006- 43: 57−62.
- Fahie-Wilson M.N. In Hyperprolactinemia, Testing for Macroprolactin Is Essential // Clinical Chemistry. 2003. — Vol. 49. — pp. 1434−1436.
- Fahie-Wilson M.N., John R., Ellis A.R. Macroprolactin- high molecular mass forms of circulating prolactin. //Ann Clin Biochem 2005, Vol. 42(3), P- 175 192.
- Fahie-Wilson M.N., McKenna T., Ahlquist J., Smith T. Macroprolactin and the Pituitary Society guidelines for the diagnosis and management of prolactinomas // Clin. Endocrinol. 2007- 67: 638−9.
- Fraser I. S. Lun Z. G., Zhou J. P. et al. Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function // Journal of Clinical Endocrinology & Metabolism. 1989. — Vol. 69. — pp. 585−592.
- Fraser I.S., Zhuang G.L. Polymers of prolactin and their clinical significance. // Obstet.Gynecol. Surv.-1990.-Vol. 45(8),-P.515−520.
- Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiological reviews 2000. Vol. 80. № 4. P. 15 231 631.
- Fruchtman S., Jackson L., Borski R. Insulin-like growth factor 1 disparately regulates prolactin and growth hormone synthesis and secretion. // Obstet. Gynecol.-2000.-Vol. 96(2). P. -243−249.
- Gadkar-Sable S., Shah C., Rosario G. et al. Progesterone receptors: various forms and functions in reproductive tissues.// Front Biosci 2005−10:P.-2118−2130.
- Gambino G.M., Beck-Peccoz P., Borgato S. Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions. // Pituitary.-1999. V. 2(3)-P. 225−231.
- Garcia Menendez L et al. Macroprolactin as etiology of hyperprolactinemia. Method for detection and clinical characterization of the entity in 39 patients // Rev Clin Esp. 2003 Oct-203(10):459−464
- Gellersen B. Kempf R, Telgmann R., DiMattia G. E. Nonpituitary human prolactin gen transcription is independent of Pit-1 and differentially controlled in lymphocytes and endometrial stroma. // Mol Endocrinol. 1994. — Vol. 8.-pp. 356−373.
- Genazzani A. R Hormone replacement therapy: the perspectives for the 21st century. //Maturitas.-1999.-Vol.31−32, 1,-P. 11−17.
- Gezer A, Atasu T, Hekim C, Stenman UH, Hekim N. Hyperprolactinaemia does not always mean hyperprolactinaemia // Eur J Obstet Gynecol Reprod Biol. 2005 Feb 1−118(2):206−208.
- Gibney J., Smith T.P., McKenna T.J. The impact on clinical practice of routine screening for macroprolactin .// J. Clin. Endocrinol. Metab. 2005. Vol. 90. № 7. P. 3927−3932.
- Ginsburg K.A. Luteal phase defect. Etilogy, diagnosis and management. // Endocr. Metab. Clin. North Am.-2002.-Vol. 21(3).-P. 85−104.
- Glezer A., Soares C.R., Vieira J.G. et al. Human macropralactin diplays low biological activity via its homologous receptor in a new sensitive bioassay.// J. Clin. Endocrinol. Metab. 2006. Vol. 91. № 3. P. 1048−1055.
- Goffm V., et al. From the molecular biology of prolactin and its receptor to the lessons learned from knocout mice models // Genetic Analysis: Biomolecular Engineering 2009- 15: 189−201.
- Hashim I.A., Aston R., Butler J., McGregor A.M., Smith C.R., Norman M. The proportion of glycosylated PRL in serum is decreased in hyperprolactinemic states. // J Clin Endocrinol. Metab. 1990. — Vol.-71(l).-P.-l 11−115.
- Hattori N. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. // Clin. Endocrinol. Metabol.-1996.-Vol.81.-N2.-P.586−590.
- Hattori N., Ikekubo K., Nakayama Y. et al. Immunoglobulin G subclasses and prolactin (PRL) isoforms in macroprolactinaemia due to anti-PRL autoantibodies.// J Clin Endocrinol Metab 2005- 90: P. 3036−3044.
- Hattori N., Nakayama Y., Kitagawa K. et al. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia// Clin Endocrinol (Oxf). 2008. — 1: Vol. 68. — pp. 72−76.
- Hauache O.M., Oliveira J.H. Tachibana T. et al. Evaluation of plasma prolactin levels. // Endocrin. Metabol.- 2006.- Vol. 50(3), P. 569−570.
- Hekim C. Alfthan H., Leinonen J.T., Stenmana U-H. Effect of Incubation Time on Recognition of Various Forms of Prolactin in Serum by the DELFIA Assay // Clinical Chemistry. 2002. — Vol. 48. — pp. 2253−2256.
- Herbert F., Sparkle D., et al. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction // Endocrin- 2009-- 9: — 602−6.
- Hornstein M.D., Schust D.J. Infertility issue. // J. Novak’s Gynecology. 1996. -Vol. 24(3), P. 915−962.
- Horseman N.D., Yu-Lee L.Y. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines// EndocrRev 1994,15: 627−649.
- Hwang P. Guyda H., Friesen H. A Radioimmunoassay for Human Prolactin//Proc Natl Acad Sci U S A 1971.-8: Vol. 68. — pp. 1902−1906.
- Jackson R.D., Wortsman J., Malarkey W.B. Persistence of large molecular weight prolactin secretion during pregnancy in women with macroprolactinemia and its presence in fetal cord blood. // J. Clin. Endocrinol. Metab. 1989.- Vol.- 68(6).P.-1046−50.
- Jeske W, Zgliczynski W, Gorzelak K. Macroprolactin in subjects with hyperprolactinaemia- clinical observations and relations between free PRL and PRL complexed with IgG. // Endocrynol. 2005. -V. 56(5). — P. 779−784.
- Kaluzny M, Bolanowski M. «Hyperprolactinemia: etiology, clinical symptoms, and therapy» // Postepy Hig Med Dosw. 2005 Feb 8−59:20−27.
- Kanuka H., Matsuyama S., Ohnishi M., Matsumoto Y., Nishihara M., Takahashi M. «Prolactin expresses differential effects on apoptotic cell death of luteal cells in vivo and in vitro» // Endocr J, 1997, 44: 11−22
- Kavanagh L., McKenna J., Fahie-Wilson M.N. et al. Specificity and clinical utility of methods for the detection of macroprolactin.// Clin Chem 2006- Vol.-52 (7), P. 1366−1372.
- Kavanagh L., Smith TP, Gibney J, McKenna TJ. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Journal. // Clin Endocrinol (Oxf). 2008. -9- pp. 1089−1094.
- Kiesel M., Graesslin D., Bettendorf G. Molecular and biochemical characterization of four size variants and six isohormones of prolactin from human pituitaries. // Endocrine surgery.-1997.-Vol. 9- P.- 62−71.
- Kletzky O.A., Piatt L., Michelle D., et al. Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancy // Obstet Gynecol 2009- 151(8): 878−84.
- Kossiakoff A.A. The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors.// Adv. Protein Chem. 2004.- Vol.- 68, P.- 147−169.
- Kramer C. K., Tourinho T. F., de Castro W. P., da Costa Oliveira M. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies // Arch Med Res.. 2005. — 1: Vol. 36.-pp. 54−58.
- Landberg E., Wahlberg J., Ryden I. et al. Detection of molecular variants of prolactin in human serum, evaluation of a method based on ultrafi ltration. Clin Chim Acta. 2007- 376: 1−2: 220- 225.
- Langenheim J.F., Tan D., Walker A.M., Chen W.Y. Two Wrongs Can Make a Right: Dimers of Prolactin and Growth Hormone Receptor Antagonists Behave as Agonists. // Mol. Endocr. 2006, — Vol. -20, P- 661−674.
- Larrea F., Escorza A., Valero A. Mactoprolactinemia revsited: A study on 106 patients.// J. Clin. Endocrinol. Metabol.-1989.-Vol.-68(5).-P. 982−7.
- Leite V., Cosby H., Sobrinho L. G., Fresnoza M. A. et al. Characterization of big, big prolactin in patients with hyperprolactinaemia // Clin Endocrinol (Oxf). 1992.-4: Vol. 37.-P. 365−372.
- Lemaire C., Dewailly D., Racadot A. et al. Hyperprolactinemia and pregnancy//Endocrinology. 2010. — V. 53(6).-P. 1203−1208.
- Lin S.H. Prolactin-releasing peptide. // Results Probl Cell Differ. 2008. -Vol. 46. — pp. 57−88.
- Markoff E., Lee D.W., Hollingsworth D.R. Glycosylated and non-glycosylated prolactin in serum during pregnancy. // Clin. Endocrinol-2008.-Vol. 67(3).-p.519−523.
- Maslar I.A., Ansbacher R. Effects of progesterone on decidual prolactin production by organ cultures of human endometrium. // Endocrinol.-1998.-V. 118. P. -2102−2108.
- Matera L., Mori M., Geuna M. et al. Prolactin in autoimmunity and antitumor defence. // J. Neuroimmunol. 2000. — Vol. 109. — N 1. — P. 47−55.
- Maure R.A. Estradiol regulates the transcription of the prolactin gene. // J Biol Chem. 1982. — Vol. 257. — pp. 2133−2136.
- McKenna T.J. Should macroprolactin be measured in all hyperprolactinaemic sera// Clin. Endocrinol. (Oxf.). 2009. Vol. 71. № 4. P. 466−469.
- McNeilly A.S., Glasier A., Jonassen J., Howie P.W. Evidence for direct inhibition of ovarian function by prolactin // J Reprod Fertil 1982, 65: 559−69.
- Meador-Woodruff JH Mansour A, Bunzow JR. et al. Distribution of D2 dopamine receptor mRNA in rat brain. // Proc Natl Acad Sci USA. -1989. Vol. 86. — pp. 7625−7628.
- Mittral. A novel «cleaved prolactin» in the rat pituitary: Part II. In vivo mammary mitogenic activity of its N-terminal 16K moiety. // Biochem Biophys Res Commun. 1980. — 4: Vol. 95. — pp. 1760−1767.
- Molitch M.E. Pathologic hyperprolactinaemia.// Endocrinol. Metab. Clin. North Am. 1992. Vol. 21. № 4. P. 877−901.
- Molitch M.E. Pituitary disorders during pregnancy. // Endocrinol. Metab. Clin. North Am. 2006. Vol. 35. № 1. P. 99−116.
- Myai K., Ichinara K., Kondo K., Mori S. Asymptomatic hyperprolactinemia and prolactinoma in general population-mass scrining bypaired assays of serum prolactine // Clin Endocrino. 1986. Vol. 25. — pp. 549 554
- Myal Y., DiMattia G.E., Gregory C.A. et al. A Bgl II RFLP at the human prolactin gene locus on chromosome 6 (PRL). // NAR .- 1991 .- Vol.19, No.5.-P.1167.
- Nicoll, C.S., Bern, H. A The comparative endocrinology of prolactin.// Endocrin. 1968.-Vol. — 24, P.-681−720.
- Orbach H. Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. // Autoimmun Rev. 2007. — 8: Vol. 6. — pp. 537−542.
- Pansini F., Bergamini C.M., Malfaccini M. Multiple molecular forms of prolactin during pregnancy in women. // J. Endocr.-1985.-Vol. 106, N1,-p.81−85.
- Parks J., Kinoshita E, Pfaffle R. Pit-1 and hypopituitarism. 11 Trends Endocrinol and Metab. 1993. — Vol. 4. — pp. 81−85.
- Pascoe-Lira D., Duran-Reyes G., Contreras-Hernandez I. et al. Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. // J Clin Endocrinol Metab.- 2001.-Vol. 86(2), P.-924−929.
- Patel O.V., Yamada O., Kizaki K. et al. Temporospatial expression of placental lactogen and prolactin-related protein-1 genes in the bovine placenta and uterus during pregnancy.// Mol Reprod Dev.-2004.-Vol. 69(2), P.-146−152.
- Pellegrini C., Sartori E., Gambera A. Functional hypothalamic amenorrhoea. //Hum. Reprod-2002.-Vol. 17(8).-p.2043−8.
- Prazeres S., Santos M.A., Ferreira H.G., Sobrinho L.G. A practical method for the detection of macroprolactinaemia using ultrafiltration. Clin Endocrinol (Oxf) 2003- 58: 6: 686—690.
- Raghupathy R., Makhseed M. Progesteron- receptor immunomodulation and anti-abortive effects. Gynecological endocrinology. The 9th World Congress of Gynecological endocrinology. Hong Kong, December 2−5, 2001.
- Ram S. Hams B., Fernando J.J., Gama R., Fahie-Wilson, M. False- positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins. // Ann Clin Biochem. 2008. — 3: Vol. 45. — pp. 256−259.
- Raudrant D, Rabe T. Progestogens with antiandrogenic properties.// Drugs 2003−63:5:P.-463−492.
- Recchi V., Hieronimus S., Creisson G. et al. Macroprolactinemia, a variety of hyperprolactinemia// Rev. Med. Interne.-1997.-Vol.l8.-N4.-p.320−323.
- Reichlin S. //Williams Textbook of Endocrinology.-9-th edition. -Philadelphia -1998.-p. 165−248.
- Robyn C., Brandts N., Rozenberg S. Advances in physiology of human lactation. // Ann. NY Acad. Sci., 1986.-Vol. 464, P. — 66−74.
- Sapin R, Schlienger JL. Macroprolactinaemia. Immunoanal Biol. // Spec 2005- 20: 280−5.
- Schindler A. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. // Maturitas 2009- 65: 3−11.
- Schindler A.E., Campagnoli C., Druckmann R. et al. Classification and pharmacology of progestins. Maturitas 2008−61:1−2:P.-171−180.
- Schlechte JA, Editorial: The macroprolactin problem.// J. Clin Endocrinol Metab 2002- 87: P.-5408−5409.
- Seeger H., Mueck A.O. Effects of dydrogesterone on the vascular system.// Gynecol. Endocrinol. 2007- 23: Vol. l:P.-2−8.
- Serri O., et al. Diagnosis and management of hyperprolactinemia.// Canadian Medical Association Journal 2003- 169(6): 575−9.
- Soares MJ. The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface.// Reprod. Biol. Endocrinol. 2004. Vol. 2. P. 52.
- Soong YK, Ferguson KM, McGarrick G, Jeffcoate SL. Size heterogeneity of immunoreactive prolactin in hyperprolactinaemic serum. Clin Endocrinol (Oxford) 1982- 16: 259−65.
- Sugiura-Ogasawara M., Ozaki Y., Sato T., et al. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations // Fertil Steril 2004- 81(2): 367−73.
- Suh H. K. Frantz A. G. Size heterogeneity of human prolactin in plasma and pituitary extracts // Journal of Clinical Endocrinology & Metabolism. -1974.-Vol. 39.-pp. 928−935.
- Vanbesien, Schiettecatte J., Anckaert E., et al. Circulating anti-prolactin auto-antibodies must be considered in the differential diagnosis of hyperprolactinaemia in adolescents // Eur J Pediatr, July 1 2002- 161(7): 373−6.
- Vilar L., Freitas M.C., Naves L.A. et al. Diagnosis and management of hyperprolactinemia. //J. Endocrinol Invest. 2008.- Vol. 31(5), P. — 436−444.
- Whittaker P.G. Wilcox T., Lind T. Maintained fertility in a patient with hyperprolactinemia due to big-big prolactin. J. Clin Endocrinol Metab 53: 863 866. // J. Clin Endocrinol Metab. 1981. — Vol. 53. — pp. 863−866.
- Yasigi R.A., Quitero C.H., Salameh W.A. Prolactin disorders. // Fertil. Steril. -1997.-Vol. 67 (2) — P.-215−225.
- Yen S., Jaffe R. Prolactin in human reproduction. Reproductive Endocrinology Physiology, Pathiphysiology, Clinical Management. 4-th Edition 1999- 257−83.
- Yuen Y.P., Lai J.P., Au K.M., Mak T.W. Macroprolactin a cause of pseudohyperprolactinaemia // Hong Kong Med J 2003- 9(2): 119−21.
- Zacur H.A. Indications for surgery in the treatment of hyperprolactinemia. // J. Reprod Med. 1999. — Vol. 44(12), — P. 1127−1231.